22nd Jan 2026 Plain language summary: ATTRibute-CM study findings on acoramidis treatment in transthyretin amyloid heart disease
26th Nov 2025 Plain language summary: real-world tafamidis study in transthyretin amyloid cardiomyopathy (ATTR-CM) patients
23rd Sep 2024 Impact of extended tafamidis treatment on quality of life in people with transthyretin amyloid cardiomyopathy (ATTR-CM)
11th Apr 2023 Plain Language Summary: long-term survival in people being treated with tafamidis for transthyretin amyloid cardiomyopathy
